Dr. Raja Seethala
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 181
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
PA license MD425568
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- UPMC Presbyterian Shadyside Pittsburgh, PA
- Magee Womens Hospital of UPMC Health System Pittsburgh, PA
Medical groups
- University of Pittsburgh Physicians (4,236 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 181
- Services billed
- 739
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 221 | 115 |
| Special stained specimen slides to examine tissue, each additional procedure | 187 | 38 |
| Pathology examination of tissue using a microscope, moderately high complexity | 125 | 62 |
| Pathology examination of specimen during surgery, first tissue block | 65 | 34 |
| Special stained specimen slides to examine tissue, initial procedure | 61 | 55 |
| Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | 39 | 31 |
| Preparation of tissue for examination by removing any calcium present | 28 | 14 |
| Pathology examination of specimen during surgery, each additional tissue block | 28 | 13 |
| Pathology examination of tissue using a microscope, moderately low complexity | 26 | 16 |
| Special stained specimen slides to examine tissue including interpretation and report | 18 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $1,908 in total to this clinician.
| Merck Sharp & Dohme LLC | $1,908 |
|---|
| Consulting Fee | $1,908 |
|---|
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC Dec 17, 2025 | Consulting Fee | $1,908 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.